Clinical trial
Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma
NCT03662841 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ablative Chemoembolization for Unresectable and Large Hepatocellular Carcinoma
- Lead sponsor
- Chinese University of Hong Kong
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 13, 2018
- Completion date
- April 28, 2023
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.